DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Muss HB, Case LD, Atkins JN. et al.
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.
J Clin Oncol 1994;
12: 1630-1638
doi:10.1200/JCO.1994.12.8.1630
We do not assume any responsibility for the contents of the web pages of other providers.